AI assistant
Solid Biosciences Inc. — Director's Dealing 2022
Mar 8, 2022
33003_dirs_2022-03-08_a2e56a7f-312b-421b-8bab-9af93178fe59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-02-10
Reporting Person: Ganot Ilan (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-10 | Common Stock | S | 463 | $1.1202 | Disposed | 2518 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1202093 | Direct |
| Common Stock | 290914 | Indirect |
Footnotes
F1: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2: Represents 1,141,462 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. Includes 2,272 shares acquired by Mr. Ganot under the Solid Biosciences Employee Stock Purchase Plan on September 1, 2021.
F3: Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.